Polymorphism in killer cell immunoglobulin-like receptors and human leukocyte antigen-c and predisposition to preeclampsia in Ethiopian pregnant women population.


Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
09 2020
Historique:
received: 21 03 2020
revised: 29 05 2020
accepted: 15 06 2020
pubmed: 1 7 2020
medline: 21 9 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

Preeclampsia (PE) is a human specific pregnancy-related syndrome of unknown etiology that affects 2-8 % of pregnancies. Polymorphism in maternal Killer Cell Immunoglobulin-like Receptors (KIRs) and the ligand fetal Human Leukocyte Antigen-C (HLA-C) may predispose pregnant mothers for PE due to defective trophoblast invasion into the maternal decidua. Our study aimed to investigate the association between maternal KIR and fetal HLA-C polymorphism and PE in Ethiopian pregnant women. We included a total of 288 (157 controls and 131 PE cases) in a case-controls study at Adama Regional Referral Hospital, Ethiopia. The KIR and HLA-C genotyping was done using traditional polymerase chain reaction on genomic DNA extracted form maternal venous and cord blood followed by 2% agarose gel electrophoresis. The statistical associations between variables were evaluated using Pearson's Chi-square test. P < 0.05, with 95 % confidence interval was considered statistically significant. A significant association was observed between the KIR2DS1 and PE, with a higher frequency (60.5 %) of the gene in the control group. Similarly, a significant association was observed between KIR AA genotype and PE, with a higher frequency (38.2 %) of this genotype in the PE group. Ethiopians share the same risk genotype for PE as seen in previous African and European studies, namely homozygosity of a maternal KIR AA genotype. However, Ethiopians differ from other East African populations by sharing the same protective KIR2DS1 gene as Europeans.

Identifiants

pubmed: 32603992
pii: S0165-0378(20)30090-5
doi: 10.1016/j.jri.2020.103169
pii:
doi:

Substances chimiques

HLA-C Antigens 0
KIR2DS1 protein, human 0
Receptors, KIR 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103169

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Tsehayneh Kelemu (T)

Department of Biochemistry, College of Health Sciences, Addis Ababa University, Ethiopia. Electronic address: tkelemu_2005@yahoo.com.

Lena Erlandsson (L)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University, Sweden. Electronic address: lena.erlandsson@med.lu.se.

Daniel Seifu (D)

Department of Biochemistry, College of Health Sciences, Addis Ababa University, Ethiopia; Department of Biochemistry, Division of Biomedical Sciences, University of Global Health Equity, Rwanda. Electronic address: abbysinia2002@gmail.com.

Eva Hansson (E)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University, Sweden. Electronic address: eva.hansson@med.lu.se.

Markos Abebe (M)

Armauer Hanson Research Institute, Ethiopia. Electronic address: markosabebe@yahoo.com.

Sisay Teklu (S)

Department of Obstetrics and Gynecology, College of Health Sciences, Addis Ababa University, Ethiopia. Electronic address: siteet@yahoo.com.

Selfu Girma (S)

Armauer Hanson Research Institute, Ethiopia. Electronic address: selfugirma2@gmail.com.

James A Traherne (JA)

Department of Pathology, University of Cambridge, Cambridge, UK. Electronic address: jat51@cam.ac.uk.

Ashley Moffett (A)

Department of Pathology, University of Cambridge, Cambridge, UK. Electronic address: am485@cam.ac.uk.

Stefan R Hansson (SR)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University, Sweden. Electronic address: stefan.hansson@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH